Test Price
2,800 AED✅ Home Collection Available
OPA3 Gene (3-Methylglutaconic Aciduria Type III) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين OPA3 (بيلة حمض الميثيل جلوتاكونيك من النوع الثالث) بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Your Guarantee
- Diagnostic Precision: 99.9% diagnostic sensitivity via ISO 9001:2015‑accredited NGS laboratory processing.
- Premium At‑Home Phlebotomy: Paid hospital‑grade home collection with ISO‑certified cold‑chain transport and VIP mobile phlebotomy service.
- Post‑Test Clinical Guidance: Dedicated telephonic consultation with a clinical expert to interpret your genetic results.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
- ضمان الامتثال الإماراتي: تحليل معتمد من هيئة الصحة بدبي وفقًا للمرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية.
Test Overview & Key Differentiators
The OPA3 Gene NGS test sequences the entire coding region of the OPA3 gene to detect pathogenic variants responsible for 3‑Methylglutaconic Aciduria Type III (Costeff syndrome), a rare autosomal recessive metabolic disorder. This gold‑standard genomic analysis replaces outdated biochemical screens, offering definitive confirmation for at‑risk individuals, carrier screening, and research-grade precision. يكشف هذا التحليل الجيني الشامل عن طفرات جين OPA3 المرتبطة بمرض بيلة حمض الميثيل جلوتاكونيك من النوع الثالث، مما يوفر تشخيصًا قاطعًا ودقيقًا يتجاوز الفحوصات الكيميائية التقليدية.
| Feature | Our OPA3 NGS Test | Closest Alternative / Biochemical Screen |
|---|---|---|
| Target | Full OPA3 gene (all exons, splice sites) – comprehensive mutation detection | Urinary organic acids only; cannot differentiate OPA3 from other 3‑MGA types |
| Method | NGS (Next‑Generation Sequencing) with >100x coverage and confirmatory Sanger | GC‑MS or tandem MS; high false‑positive rate |
| Turnaround | 3 to 4 Weeks | 1–2 weeks but requires invasive second‑tier testing |
| Specimen | Whole blood, extracted DNA, or a single drop on FTA card | Fresh urine, strict collection conditions |
| Clinical Utility | Definitive diagnosis, carrier identification, family planning, targeted therapy | Screening only; often requires molecular confirmation |
Physician Insight & Safety Protocol
From the Desk of Dr. PRABHAKAR REDDY, DHA‑Licensed Consultant (License 61713011): Genetic testing for OPA3 provides life‑changing clarity for families affected by unexplained metabolic crises. Every result must be correlated with the patient’s full clinical history, including early‑onset optic atrophy, movement disorders, and biochemical markers. I urge you to view this report not as a solitary answer, but as the starting point for a multidisciplinary care plan that safeguards your child’s future.
Medication & Safety Warning
⚠️ Do not discontinue any prescribed medication or metabolic diet without explicit instruction from your managing physician.
This genetic test is diagnostic and cannot replace acute medical assessment. If the patient exhibits sudden vomiting, extreme lethargy, hypoglycemia, or altered consciousness, seek emergency care immediately.
Exclusion Criteria for Specimen Collection
- Active febrile illness or systemic infection at time of blood draw.
- Known coagulopathy or severe thrombocytopenia without physician clearance.
- Inability to provide informed consent (patients under 18 require legally authorized guardian’s consent per UAE CDS Law 2026).
Emergency Red Flags Post‑Test
- New‑onset metabolic acidosis, persistent vomiting, or seizures.
- Sudden visual loss or strabismus in a previously asymptomatic individual.
- Any sign of acute encephalopathy – proceed to nearest emergency department immediately.
Patient FAQ & Clinical Guidance
Q1: What conditions does the OPA3 gene test diagnose, and why should I choose NGS over older methods?
Snippet‑first answer: This test definitively diagnoses 3‑Methylglutaconic Aciduria Type III (Costeff syndrome) by identifying pathogenic variants in the entire OPA3 gene. NGS offers >99% diagnostic sensitivity and detects novel mutations missed by targeted panels or biochemical assays, enabling precise family counselling and risk prediction.
ج: يشخص هذا الاختبار بدقة مرض بيلة حمض الميثيل جلوتاكونيك من النوع الثالث (متلازمة كوستيف) من خلال تحليل شامل لجين OPA3 وراثيًا.
Q2: How is the sample collected, and what is the exact process from booking to result delivery in the UAE?
Snippet‑first answer: A certified phlebotomist visits your home between 8 AM and 11 PM for a painless venous blood draw, or you can submit pre‑extracted DNA or an FTA card. Our cold‑chain logistics preserve sample integrity until it reaches our ISO‑accredited lab; you receive a secure, encrypted report within 3 to 4 weeks with optional post‑test tele‑consultation.
ج: يتم سحب عينة الدم منزليًا بواسطة أخصائي مرخص بين 8 صباحًا و11 مساءً، مع خيار بطاقة FTA أو الحمض النووي المستخلص، ثم تُحفظ بسلسلة تبريد معتمدة.
Q3: Can I trust the privacy of my genetic data and is the compliant with UAE health data laws?
Snippet‑first answer: Absolutely – all genetic data is processed under strict UAE PDPL, Federal Decree‑Law No. 41 of 2024, and our ISO 9001:2015 certification guarantees confidentiality. Your sample is de‑identified upon arrival, results are shared only through encrypted channels, and we never store or share data without explicit written consent.
ج: نعم، نلتزم بقانون حماية البيانات الشخصية الإماراتي والمرسوم بقانون اتحادي رقم 41، وجميع المعلومات الجينية مشفرة ومحمية بموافقة خطية صريحة.
ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139) | DHA License: 9834453 | All testing adheres to 2026 DHA/MOHAP NGS standards and Federal Decree‑Law No. 41 of 2024, Art. 87.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians